Viatris Inc

NASDAQ: VTRS
$11.59
+$0.16 (+1.4%)
Closing Price on October 4, 2024

VTRS Stock Chart and Intraday Price

VTRS Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 235 EAST 42ND STREET, NEW YORK, NY, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 15,103.85M USD
Shares Outstanding 1,199,670,000
Viatris Inc is a global healthcare company that provides a wide range of products, including prescription brand drugs, generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) across various therapeutic areas. With a focus on both noncommunicable and infectious diseases, the company offers treatments in oncology, immunology, endocrinology, ophthalmology, and dermatology among others. Viatris distributes its products to retail and pharmacy establishments, wholesalers, insurers, and governments worldwide, ensuring access to quality medicines. Founded in 1961 and based in Canonsburg, Pennsylvania, Viatris is committed to supporting patient health through its extensive portfolio and services.

VTRS Articles

Monday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Accenture, Clorox, Fiserv, Moderna, Planet Fitness, Sarepta Therapeutics, Tesla, Under Armour, Ventas, Viatris,...
Friday's top analyst upgrades and downgrades included Activision Blizzard, Altria, AppLovin, Bumble, Cano Health, Hanesbrands, Okta, Palo Alto Networks, Redfin, RingCentral, Rivian Automotive,...
Wednesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Eli Lilly, Home Depot, Medtronic, Palantir Technologies, Snowflake, Take-Two Interactive Software, Viatris and...
Before U.S. markets open Monday morning, these four companies will be reporting quarterly earnings.